Evidence map›Paper›PMID 41471032›Full record

ArticlePharmaceutics2025

Bridging Literature and Real-World Evidence: External Evaluation and Development of Fluoxetine Population Pharmacokinetics Model.

Bing Han, Nuo Xu, Chen Ma, Gehang Ju, Xie Xi, Cheng Qian, Nan Guo, Xin Liu, Xiao Zhu, Cong Li and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bing HanSchool of Pharmaceutical Sciences, Fudan University, Shanghai 201203, China.
Nuo XuSchool of Pharmaceutical Sciences, Fudan University, Shanghai 201203, China.ORCID 0009-0003-3543-663X
Chen MaSchool of Pharmaceutical Sciences, Fudan University, Shanghai 201203, China.
Gehang JuInstitute of Big Data, Central South University, Changsha 410083, China.
Xie XiDepartment of Medical Laboratory, Hunan Prevention and Treatment Institute for Occupational Diseases, Affiliated Prevention and Treatment Institute for Occupational Diseases of University of South China, Changsha 410007, China.
Cheng QianSchool of Pharmaceutical Sciences, Fudan University, Shanghai 201203, China.
Nan GuoMinhang Hospital, Fudan University, Shanghai 201100, China.
Xin LiuSchool of Pharmaceutical Sciences, Fudan University, Shanghai 201203, China.ORCID 0009-0009-5595-3195
Xiao ZhuSchool of Pharmaceutical Sciences, Fudan University, Shanghai 201203, China.ORCID 0000-0003-3295-619X
Cong LiSchool of Pharmaceutical Sciences, Fudan University, Shanghai 201203, China.
Li LiuDepartment of Clinical Pharmacology and Clinical Trial, The Second People's Hospital of Hunan Province (Brain Hospital of Hunan Province), Changsha 410007, China.

Funding

the Medical Specialty Project of Minhang District 2025-2027, No. 2025MWTZB04
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

external evaluationfluoxetinemodel-informed precision dosingpopulation pharmacokinetics

Identifiers

PMID41471032
PMCPMC12736537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.